Showing results (71-80 of 361) with videos related to

Sort By:
Pageof 37
Trends in Cancer|March 25, 2022
The gut-liver axis: host microbiota interactions shape hepatocarcinogenesisMaruhen A D Silveira, Steve Bilodeau, Tim F Greten, et al.
Journal of Hepatology|December 3, 2020
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysisSophia Heinrich, Amanda J Craig, Lichun Ma, et al.
Carcinogenesis|July 10, 2023
The current landscape of therapies for hepatocellular carcinomaKelley Coffman-D'Annibale, Changqing Xie, Donna M Hrones, et al.
Plos One|November 18, 2014
Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damageTobias Eggert, José Medina-Echeverz, Tamar Kapanadze, et al.
Cancer Research|March 23, 2005
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinomaLars A Ormandy, Tina Hillemann, Heiner Wedemeyer, et al.
European Journal of Gastroenterology & Hepatology|November 27, 2009
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinomaMarkus Peck-Radosavljevic, Tim F Greten, Johannes Lammer, et al.
Immunology|August 20, 2009
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinomaFei Zhao, Sonja Obermann, Reinhard von Wasielewski, et al.
Nature Reviews. Gastroenterology & Hepatology|January 25, 2023
Immunology and immunotherapy of cholangiocarcinomaTim F Greten, Robert Schwabe, Nabeel Bardeesy, et al.
Pageof 37